| Identification | Back Directory | [Name]
DNDI-6148 | [CAS]
2243909-59-1 | [Synonyms]
DNDI-6148
N-(1-Hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-6-yl)-5-methyl-1-(2-pyridyl)-1H-1,2,3-triazole-4-carboxamide | [Molecular Formula]
C16H14BN5O3 | [MOL File]
2243909-59-1.mol | [Molecular Weight]
335.13 |
| Hazard Information | Back Directory | [Uses]
DNDI-6148 is a novel preclinical candidate for the research of visceral leishmaniasis. | [IC 50]
Leishmania | [References]
[1] Mowbray CE, et al. DNDI-6148: A Novel Benzoxaborole Preclinical Candidate for the Treatment of Visceral Leishmaniasis. J Med Chem. 2021 Nov 11;64(21):16159-16176. DOI:10.1021/acs.jmedchem.1c01437 |
|
|